Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada

Jul 21, 2026 3:35 pm | JPost BizTech, Technology

Medications. Ilustrative. (photo credit: SHUTTERSTOCK)
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
|  Read More  JPost.com – Tech | The Jerusalem Post 

0 Comments

FREE ISRAEL DAILY EMAIL!

BREAKING NEWS

JNS